IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

General Catalyst Group Management, LLC

Q2 2026 Holdings

Filed 2026-08-17 | 14 holdings | $188.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
ArriVent BioPharma, Inc.(AVBP)COM04272N102$51.9M1,494,78627.5%
Parabilis Medicines, Inc.(PBLS)COM698955101$43.8M1,600,93723.2%
Maplebear, Inc.(CART)COM565394103$33.7M710,71117.9%
Maze Therapeutics, Inc.(MAZE)COM578784100$30.9M1,035,91016.4%
Odyssey Therapeutics, Inc.(ODTX)COMMON STOCK67613T104$15.2M810,2728.0%
Eikon Therapeutics, Inc.(EIKN)COM282564103$4.0M305,2332.1%
Fractyl Health, Inc.(GUTS)COM35168W103$3.9M4,884,1862.1%
Ethos Technologies, Inc.(LIFE)CL A29765A101$1.3M74,1790.7%
Coupang Inc.(CPNG)CL A22266T109$949.7K54,6770.5%
Amazon.com Inc.(AMZN)COM023135106$925.2K3,8820.5%
Meta Platforms Inc.(META)CL A30303M102$743.5K1,3200.4%
Doordash Inc.(DASH)CL A25809K105$525.9K2,8500.3%
Carvana Co(CVNA)CL A146869102$425.5K6,4650.2%
Figma, Inc.(FIG)CLASS A COM STK316841105$268.5K14,8450.1%